Trade Review 2: PFE

Day 1 and it's my 2nd review already?! Btw I will update the results of my trades after they're done.

Trade 2: $Pfizer (PFE.US)$ . Well, this is going to be a no-brainer. Reasons:

1) I did not expect Covid -19 to last this long Pfizer has done well with its vaccine rollouts this past year and bottomline revenue should be strong.

2) The outlook for the year should still be decent with more vaccines being delivered, continued combat against variants, booster shots etc. Pfizer's core business should also be boosted with its involvement here.

3) Pharma companies have done well this earnings season and I have profited off of them such as $AbbVie (ABBV.US)$ as seen below.